Home / business / Gilead to End Coronavirus Drug Trials, Adding to Access Worry: Researchers

Gilead to End Coronavirus Drug Trials, Adding to Access Worry: Researchers

-
Preliminary results from a trial conducted by the US National Institutes of Health showed that Remdesivir cut hospital stays by 31% compared to a placebo.

from Top Business News- News18.com
Read The Rest:timesnownews...
Gilead to End Coronavirus Drug Trials, Adding to Access Worry: Researchers Gilead to End Coronavirus Drug Trials, Adding to Access Worry: Researchers Reviewed by Team Exprssnews on May 15, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.